Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
Clinical trial NCT02884206 · COMPLETED
Trial details
- NCT number
- NCT02884206
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-23
- Primary completion
- 2022-05-16
- Enrollment
- 592
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.